Full Text
Payer Management And Pricing Dynamics For Non-Oncology Pharmacy Benefit Orphan Drugs For Rare Diseases In The United States Launched 2004-2014

Abstract

Authors

RR Dalsania MJ Leibfried SK Richardson

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×